|
| Up-regulated miRNA | Target genes | Functions | Reference |
|
| hsa-mir-1289-1 | Interferon regulatory factor 2 | IFN response | [20] |
|
| hsa-mir-140,hsa-mir-320c | v-yes-1 Yamaguchi sarcoma viral oncogene homolog 1 | Oncogene | [20] |
|
| hsa-mir-421 | v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog | ć | [21] |
|
| hsa-mir-1226 | Interleukin 10 receptor, beta | Immune response | [20] |
|
| hsa-mir-1290 | Nuclear receptor coactivator 2 | Transcriptional regulators | [20] |
|
| hsa-mir-320c,hsa-mir-1290 | Transcription factor AP-2 beta | | [20] |
|
| hsa-mir-320c | pre-B-cell leukemia homeobox 3 | ć | [21] |
|
| hsa-mir-636,hsa-miR-1979,hsa-mir-1302,hsa-mir-518c,hsa-mir-1226,hsa-mir-1290,hsa-mir-421,hsa-mir-21,hsa-mir-140 | ribosomal protein S6 kinase | Kinases and phosphatases | [20] |
|
| hsa-mir-1289-1,hsa-mir-1272,hsa-mir-421 | Splicing factor, arginine/serine-rich 1 | RNA synthesis and modification | [20] |
|
| hsa-mir-1272,hsa-mir-140,hsa-mir-636 | Neuro-oncological ventral antigen 1 | Neuron specific | [20] |
|
| hsa-mir-539 | DEAD (Asp-Glu-Ala-Asp) box polypeptide 5 | | [21] |
|
| hsa-mir-1254,hsa-mir-627,hsa-mir-320c,hsa-mir-421,hsa-mir-21,hsa-mir-140 | cyclin-dependent kinase 6 | cell cycle | [21] |
|
| hsa-mir-619 | protocadherin 9 | cell adhesion | [21] |
|
| hsa-mir-627 | RER1 retention in endoplasmic reticulum 1 homolog (S. cerevisiae) | trafficking and targeting proteins | [21] |
|
| hsa-mir-140 | sorting nexin 2 | | [21] |
|
| hsa-mir-1289-1 | xenotropic and polytropic retrovirus receptor | Cellular receptors | [21] |
|
| hsa-mir-21 | interleukin 12A (natural killer cell stimulatory factor 1, cytotoxic lymphocyte maturation factor 1, p35) | cell signalling, extracellular communication | [21] |
| hsa-mir-1178,hsa-mir-140 | transforming growth factor, alpha | | [21] |
|
| hsa-mir-1178 | dual specificity phosphatase 6 | intracellular trasducers/effector/modulators | [21] |
|
